Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
34.54
-0.73 (-2.07%)
At close: Mar 5, 2026, 4:00 PM EST
34.37
-0.17 (-0.49%)
Pre-market: Mar 6, 2026, 7:09 AM EST
Tyra Biosciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Tyra Biosciences stock have an average target of 44.63, with a low estimate of 30 and a high estimate of 59. The average target predicts an increase of 29.21% from the current stock price of 34.54.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tyra Biosciences stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 3 | 4 | 4 |
| Buy | 3 | 3 | 2 | 3 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 6 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $45 | Strong Buy | Maintains | $30 → $45 | +30.28% | Feb 17, 2026 |
| Wedbush | Wedbush | Buy Maintains $37 → $53 | Buy | Maintains | $37 → $53 | +53.45% | Feb 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $36 → $50 | Buy | Maintains | $36 → $50 | +44.76% | Feb 3, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $32 → $43 | Strong Buy | Maintains | $32 → $43 | +24.49% | Feb 3, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.02
from -1.51
EPS Next Year
-2.31
from -2.02
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.01 | -1.71 | ||||
| Avg | -2.02 | -2.31 | ||||
| Low | -2.03 | -2.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.